Our Comprehensive Services
PD Partners provides integrated pharmaceutical development, analytical testing, and validation services to support projects ranging from over-the-counter products to complex prescription drug formulations.
Our experienced team works collaboratively with clients throughout formulation development, analytical method development and validation, stability studies, and quality testing. By identifying technical challenges early and implementing scientifically sound development strategies, we help clients minimize costly delays, improve development efficiency, and maintain a strong focus on product quality and regulatory requirements.
Explore our comprehensive services to discover how PD Partners can support your next pharmaceutical development project:
FDA Regulatory Submissions & ANDA Expertise
Successfully navigating the FDA regulatory approval process requires more than generating analytical data. It demands a comprehensive understanding of pharmaceutical development, regulatory expectations, and the documentation necessary to support a successful submission.
With extensive experience preparing and submitting Abbreviated New Drug Applications (ANDAs) to the FDA, PD Partners provides the regulatory expertise needed to guide pharmaceutical products through the development and submission process. Our integrated approach ensures that formulation development, analytical method validation, stability studies, and regulatory documentation are aligned with applicable FDA requirements.
From initial development strategies through regulatory submission, we work closely with clients to anticipate potential challenges, streamline the submission process, and advance their products toward FDA approval and commercialization.
Scientific Expertise. Quality-Driven Development.
For more than 20 years, PD Partners has helped pharmaceutical companies develop and improve drug products through scientifically sound development practices and an unwavering commitment to quality. As an FDA-registered and FDA-inspected, cGMP-compliant facility, our laboratory operates under established quality systems designed to meet the rigorous requirements of pharmaceutical development and testing.
Our extensive experience in formulation development, analytical testing, validation, and regulatory submissions enables us to identify potential challenges early and develop practical solutions to complex technical problems. From selecting appropriate active pharmaceutical ingredients (APIs) and excipients to establishing reliable analytical methods and evaluating product stability, we integrate scientific expertise, quality, and regulatory considerations throughout the development process.
At PD Partners, we believe successful pharmaceutical development requires more than technical capabilities. It demands scientific integrity, regulatory expertise, attention to detail, and a commitment to quality. These principles guide our work and form the foundation of the long-term relationships we build with our clients.
We understand that delays in formulation development, analytical testing, validation, or regulatory submissions can have significant financial and operational consequences. By combining our scientific expertise, established cGMP quality systems, and extensive FDA regulatory experience, we help clients anticipate challenges, improve development efficiency, and advance their pharmaceutical programs with confidence.
Product Development Expertise Across Industries
PD Partners brings decades of experience supporting pharmaceutical, healthcare, and consumer health companies in the development of new products and improvement of existing formulations. Our scientific and analytical expertise allows us to identify potential formulation, testing, and regulatory challenges early in the development process, helping clients minimize costly delays and improve development efficiency.
From initial concept through product development and analytical testing, we provide the technical expertise and collaborative support needed to advance your projects.
Explore how PD Partners can support your industry:
Qualified and Experienced Product Testing
As a DEA-registered analytical laboratory authorized to handle Schedule I controlled substances, PD Partners offers specialized analytical testing services for cannabinoid-containing pharmaceutical products. Our laboratory provides quantitative cannabinoid analysis and comprehensive analytical testing to support pharmaceutical development, product quality evaluation, and applicable regulatory requirements.
Developing pharmaceutical products containing controlled substances requires scientific expertise and a thorough understanding of federal regulatory requirements. PD Partners works closely with clients to establish appropriate testing strategies, evaluate product specifications, and generate reliable analytical data to support their development programs and regulatory objectives.
With extensive experience in pharmaceutical development and analytical testing, PD Partners provides the scientific expertise, laboratory capabilities, and personalized support needed to advance your projects. Our integrated analytical testing, controlled storage, and stability services offer efficient, cost-effective solutions while maintaining a strong commitment to data integrity, scientific excellence, and quality.
